Literature DB >> 10552025

MRI of the intracranial corticospinal tracts in amyotrophic and primary lateral sclerosis.

P Peretti-Viton1, J P Azulay, S Trefouret, H Brunel, C Daniel, J M Viton, A Flori, B Salazard, J Pouget, G Serratrice, G Salamon.   

Abstract

Our aim was to investigate the corticospinal tracts (CST) in motor neurone disease, using MRI, and to correlate findings with clinical data. We studied 31 patients with amyotrophic (ALS) and eight with primary lateral sclerosis (PLS). The signal from the CST was classified into four grades on T2-weighted images, and compared to T2-weighted images of 37 age-matched control subjects. No abnormalities were seen in the CST on T1-weighted images and were rarely evident on proton-density weighting. Variable high signal in the CST was found on T2-weighted images in 35 patients, and in 29 control subjects. Our grades 0 and 1 were more frequent in control subjects, grades 2 and 3 more frequent in patients. We found no correlation between the high signal and clinical data, including the duration of the illness. We therefore conclude that this technique is neither sensitive nor specific except in grade 3 which is quite specific for ALS. In half the patients we found atrophy of the superior parietal gyrus, which merits further study.

Entities:  

Mesh:

Year:  1999        PMID: 10552025     DOI: 10.1007/s002340050836

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  15 in total

1.  Advances in the application of MRI to amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michel Modo
Journal:  Expert Opin Med Diagn       Date:  2010-11

2.  High T2 signal in primary lateral sclerosis supports the topographic distribution of fibers in the corpus callosum: assessing disease in the primary motor segment.

Authors:  S M Riad; H Hathout; J C Huang
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

Review 3.  Primary Lateral Sclerosis.

Authors:  Jeffrey M Statland; Richard J Barohn; Mazen M Dimachkie; Mary Kay Floeter; Hiroshi Mitsumoto
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 4.  Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.

Authors:  Stefanie M A Willekens; Donatienne Van Weehaeghe; Philip Van Damme; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-08       Impact factor: 9.236

5.  Cortical T2 signal shortening in amyotrophic lateral sclerosis is not due to iron deposits.

Authors:  M J Hecht; C Fellner; A Schmid; B Neundörfer; F A Fellner
Journal:  Neuroradiology       Date:  2005-09-21       Impact factor: 2.804

6.  Gray matter perfusion correlates with disease severity in ALS.

Authors:  Randall R Rule; Norbert Schuff; Robert G Miller; Michael W Weiner
Journal:  Neurology       Date:  2010-02-10       Impact factor: 9.910

7.  Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS.

Authors:  S G Mueller; N Schuff; M W Weiner
Journal:  NMR Biomed       Date:  2006-10       Impact factor: 4.044

8.  Combined MR spectroscopic imaging and diffusion tensor MRI visualizes corticospinal tract degeneration in amyotrophic lateral sclerosis.

Authors:  Hong Yin; C C Tchoyoson Lim; Lin Ma; Yuangui Gao; Youquan Cai; Dejun Li; Yan Liang; Xinggao Guo
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

9.  Abnormal cortical excitability in sporadic but not homozygous D90A SOD1 ALS.

Authors:  M R Turner; A D Osei-Lah; A Hammers; A Al-Chalabi; C E Shaw; P M Andersen; D J Brooks; P N Leigh; K R Mills
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

10.  Magnetic resonance microscopy and immunohistochemistry of the CNS of the mutant SOD murine model of ALS reveals widespread neural deficits.

Authors:  M S Petrik; J M B Wilson; S C Grant; S J Blackband; R C Tabata; X Shan; C Krieger; C A Shaw
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.